These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3086650)

  • 1. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine.
    Petraglia F; Porro C; Facchinetti F; Cicoli C; Bertellini E; Volpe A; Barbieri GC; Genazzani AR
    Life Sci; 1986 Jun; 38(23):2103-10. PubMed ID: 3086650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
    Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
    Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
    Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
    Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
    Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP; Skupny A
    J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
    Cetel NS; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of morphine and naloxone on plasma levels of LH, FSH, prolactin and growth hormone in the immature male pig.
    Trudeau VL; Meijer JC; van de Wiel DF; Bevers MM; Erkens JH
    J Endocrinol; 1988 Dec; 119(3):501-8. PubMed ID: 3146613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
    J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
    Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
    Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The source of pulsatile secretion of progesterone during the human follicular phase.
    Judd S; Terry A; Petrucco M; White G
    J Clin Endocrinol Metab; 1992 Feb; 74(2):299-305. PubMed ID: 1730808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naloxone and morphine on the proestrous surge of prolactin and gonadotropins in the rat.
    Ieiri T; Chen HT; Campbell GA; Meites J
    Endocrinology; 1980 May; 106(5):1568-70. PubMed ID: 6767598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile, and postmenopausal women.
    Genazzani AD; Petraglia F; Volpogni C; D'Ambrogio G; Facchinetti F; Genazzani AR
    Am J Physiol; 1993 May; 264(5 Pt 1):E776-81. PubMed ID: 8498499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol effects on naloxone-stimulated luteinizing hormone, prolactin and estradiol in women.
    Mendelson JH; Mello NK; Cristofaro P; Ellingboe J; Skupny A; Palmieri SL; Benedikt R; Schiff I
    J Stud Alcohol; 1987 Jul; 48(4):287-94. PubMed ID: 3613578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lactating sows with the dopamine agonist Cabergoline: effects on LH and prolactin secretion and responses to challenges with naloxone and morphine.
    De Rensis F; Quintavalla F; Foxcroft GR
    Anim Reprod Sci; 1998 May; 51(3):233-47. PubMed ID: 9675405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.